- Home
- Publications
- Publication Search
- Publication Details
Title
Pituitary-Directed Therapies for Cushing’s Disease
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-01
DOI
10.3389/fendo.2018.00164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide
- (2018) V. Guarnotta et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Pregnancy and Tumor Outcomes in Women with Prolactinoma
- (2017) Bárbara Araujo et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- MicroRNAs in pituitary tumors
- (2017) Anne Wierinckx et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review
- (2017) Fabienne Langlois et al. Pituitary
- Silibinin protects against osteoarthritis through inhibiting the inflammatory response and cartilage matrix degradation in vitro and in vivo
- (2017) Wenhao Zheng et al. Oncotarget
- Vitamin A, endocrine tissues and hormones: interplay and interactions
- (2017) J Brossaud et al. Endocrine Connections
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: DIAGNOSIS OF RECURRENCE IN CUSHING DISEASE
- (2016) Maria Fleseriu et al. Endocrine Practice
- ALD1613, A Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology
- (2016) Andrew L. Feldhaus et al. ENDOCRINOLOGY
- Cabergoline for Cushing’s disease: a large retrospective multicenter study
- (2016) A Ferriere et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cabergoline treatment for recurrent Cushing’s disease during pregnancy
- (2016) Afif Nakhleh et al. Hormones-International Journal of Endocrinology and Metabolism
- A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline
- (2016) William M. Drake et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance
- (2016) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of retinoic acid on human adrenal corticosteroid synthesis
- (2016) Antonella Sesta et al. LIFE SCIENCES
- Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors
- (2016) Yona Greenman et al. Pituitary
- Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
- (2016) Julie M. Silverstein Pituitary
- The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
- (2016) Lucio Vilar et al. International Journal of Endocrinology
- Recurrent gain-of-function USP8 mutations in Cushing's disease
- (2015) Zeng-Yi Ma et al. CELL RESEARCH
- Medical Treatment of Cushing Disease
- (2015) Maria Fleseriu ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
- (2015) K. Hayashi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
- (2015) P. Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- THERAPY OF ENDOCRINE DISEASE: Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence
- (2015) S. Petersenn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease
- (2015) Fatemeh G. Amlashi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease
- (2015) Ning-Ai Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
- (2015) Filippo Ceccato et al. JOURNAL OF NEURO-ONCOLOGY
- Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling
- (2015) D. K. Nambiar et al. MOLECULAR CANCER THERAPEUTICS
- A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease
- (2015) Mathias Riebold et al. NATURE MEDICINE
- Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
- (2015) Songwei Duan et al. NEUROBIOLOGY OF AGING
- Cushing's disease: current medical therapies and molecular insights guiding future therapies
- (2015) Darryl Lau et al. Neurosurgical Focus
- Medical combination therapies in Cushing’s disease
- (2015) Lucio Vilar et al. Pituitary
- Osilodrostat (LCI699), a potent 11β-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats
- (2015) Li Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The New Molecular Landscape of Cushing's Disease
- (2015) Silviu Sbiera et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
- (2014) Rosario Pivonello et al. CLINICAL ENDOCRINOLOGY
- Treatment of Cushing's disease: a mechanistic update
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF ENDOCRINOLOGY
- MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
- (2014) Christopher J. Cheng et al. NATURE
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease
- (2014) Martin Reincke et al. NATURE GENETICS
- High variability in baseline urinary free cortisol values in patients with Cushing's disease
- (2013) S. Petersenn et al. CLINICAL ENDOCRINOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
- (2013) Maria Fleseriu et al. JOURNAL OF NEURO-ONCOLOGY
- Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial
- (2013) Jessica MacKenzie Feder et al. Pituitary
- Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease
- (2013) L. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temozolomide in aggressive pituitary adenomas and carcinomas
- (2012) LD Ortiz et al. Clinics
- Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study
- (2012) H. Dietrich et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Potential Role for Retinoic Acid in Patients with Cushing's Disease
- (2012) Francesca Pecori Giraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical management of Cushing’s disease: what is the future?
- (2012) Maria Fleseriu et al. Pituitary
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
- (2011) N.-A. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of Cabergoline in Uncured (Persistent or Recurrent) Cushing Disease After Pituitary Surgical Treatment with or without Radiotherapy
- (2010) Anurag Lila et al. Endocrine Practice
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells
- (2010) Massimo Mannelli et al. NEUROENDOCRINOLOGY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
- (2009) D Dworakowska et al. ENDOCRINE-RELATED CANCER
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Immunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas
- (2009) Zachary M. Bush et al. Pituitary
- Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease
- (2009) Lucio Vilar et al. Pituitary
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2008) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Late-Night Salivary Cortisol for Diagnosis of Overt and Subclinical Cushing’s Syndrome in Hospitalized and Ambulatory Patients
- (2008) Marie-Laure Nunes et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
- (2008) Rosario Pivonello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome
- (2008) C. de Bruin et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search